Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Obesity × Leuprolide × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 159 Breast Neoplasms 23 Neoplasms 9 Leiomyoma 8 Polycystic Ovary Syndrome 5 Neoplasm Metastasis 3 Adenocarcinoma 3 Salivary Gland Neoplasms 2 Rare Diseases 2 Prostate Adenocarcinoma 2 Premenopausal Breast Cancer 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Breast Neoplasms, Male 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urogenital Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Skin Diseases 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasm Duct 1 Respiratory Tract Diseases 1 Recurrence 1 Puberty, Precocious 1 Prostatic Diseases 1 Primary Dysautonomias 1 Patient Compliance 1 PSA Level Greater Than Two 1

Interventions

Exercise 22 Metformin 18 Tirzepatide 8 Diet 8 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 7 Resistance Training 6 Early Intervention, Educational 6 Caloric Restriction 6 semaglutide 5 Exenatide 5 Diet, Mediterranean 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Docosahexaenoic Acids 4 Bariatric Surgery 4 exemestane 3 Vitamin D 3 Tamoxifen 3 Standard of Care 3 Observation 3 Naltrexone 3 Dexamethasone 3 Bupropion 3 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01422096 2018-07-19

CBS007

University of Virginia

Phase EARLY_PHASE1 Withdrawn

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡